KALA BIO, Inc.
KALA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479419
No open-market purchases or sales by KALA BIO, Inc. insiders were filed in the last 90 days; 15 institutions reported holding it in 13F filings for Q2 2026, worth $1.21M in total; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding KALA BIO, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Of which not filed for Q3 2021 | Q3 2021 | Change |
|---|---|---|---|---|
| Holders | 107 | 1 | 108 | +2 |
| Shares | 32.3M | 392.1K | 30.3M | −1.64M (−5.1%) |
| Value | $171.3M | $2.08M | $79.5M | −$89.7M (−53.0%) |
1 institution that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (18)
Institutions that held KALA BIO, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management SA | 392,107 | $1.03M | 0.00% |
| Renaissance Technologies LLC | 166,100 | $435.0K | 0.00% |
| Towercrest Capital Management | 122,500 | $321.0K | 0.06% |
| Jump Financial, LLC | 43,500 | $114.0K | 0.01% |
| Walleye Capital LLC | 36,642 | $96.0K | 0.00% |
| Bank of Montreal | 22,914 | $68.0K | 0.00% |
| Virginia Retirement Systems Et Al | 25,000 | $66.0K | 0.00% |
| SG Americas Securities, LLC | 25,373 | $66.0K | 0.00% |
| Gsa Capital Partners LLP | 25,375 | $66.0K | 0.01% |
| Rafferty Asset Management, LLC | 24,592 | $64.0K | 0.00% |
| Csenge Advisory Group | 19,250 | $53.0K | 0.00% |
| Macquarie Group Ltd | 19,498 | $51.0K | 0.00% |
| LPL Financial LLC | 17,450 | $46.0K | 0.00% |
| Newbridge Financial Services Group, Inc. | 14,216 | $37.0K | 0.02% |
| Evoke Wealth, LLC | 8,000 | $20.0K | 0.00% |
| Berman Capital Advisors, LLC | 1,260 | $3.00K | 0.00% |
| Allworth Financial LP | 37 | $0 | 0.00% |
| Quadrant Capital Group LLC | 166 | $0 | 0.00% |
Sold out (16)
Institutions that held KALA BIO, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Jupiter Asset Management Ltd | 174,650 | $920.0K |
| Centiva Capital, LP | 58,317 | $309.0K |
| Bridgefront Capital, LLC | 47,569 | $252.0K |
| Ensign Peak Advisors, Inc | 46,091 | $244.0K |
| Mesirow Financial Investment Management, Inc. | 42,104 | $223.0K |
| Schonfeld Strategic Advisors LLC | 40,823 | $216.0K |
| Manufacturers Life Insurance Company, The | 30,389 | $161.0K |
| Mercer Global Advisors Inc | 20,370 | $108.0K |
| Jane Street Group, LLC | 16,644 | $88.0K |
| Winton Group Ltd | 15,667 | $83.0K |
| Tudor Investment Corp Et Al | 11,912 | $63.0K |
| Point72 Hong Kong Ltd | 10,178 | $54.0K |
| Private Capital Group, LLC | 325 | $2.00K |
| US Bancorp | 134 | $1.00K |
| FMR LLC | 1 | $0 |
| Signaturefd, LLC | 44 | $0 |
Not filed for Q3 2021 yet (1)
Institutions that held KALA BIO, Inc. at the end of Q2 2021 and haven't filed a 13F for Q3 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Pictet Asset Management Ltd | 392,107 | $2.08M |